Karen A. Dawes - Jun 10, 2025 Form 4 Insider Report for Barinthus Biotherapeutics plc. (BRNS)

Role
Director
Signature
/s/ William Enright, Attorney-in-Fact
Stock symbol
BRNS
Transactions as of
Jun 10, 2025
Transactions value $
$0
Form type
4
Date filed
6/11/2025, 05:10 PM
Previous filing
May 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
DAWES KAREN A Director UNIT 6-10, ZEUS BUILDING, RUTHERFORD AVENUE, HARWELL, DIDCOT, UNITED KINGDOM /s/ William Enright, Attorney-in-Fact 2025-06-11 0001261506

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BRNS Share Option (Right to Buy) Award $0 +20.2K $0.00 20.2K Jun 10, 2025 Ordinary Shares 20.2K $1.00 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option shall vest in full on the earlier of (i) June 10, 2026 or (ii) the next annual meeting of shareholders of the Issuer, subject to the Reporting Person's continued service as a director through the applicable vesting date.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.